1999
DOI: 10.1001/archpsyc.56.11.1043
|View full text |Cite
|
Sign up to set email alerts
|

Reduced Cortical γ-Aminobutyric Acid Levels in Depressed Patients Determined by Proton Magnetic Resonance Spectroscopy

Abstract: This study provides the first evidence of abnormally low cortical GABA concentrations in the brains of depressed patients.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

24
382
7
8

Year Published

2001
2001
2012
2012

Publication Types

Select...
8

Relationship

3
5

Authors

Journals

citations
Cited by 552 publications
(421 citation statements)
references
References 33 publications
(39 reference statements)
24
382
7
8
Order By: Relevance
“…Also, SSRIs are known to increase GABA levels in the brain of depressed patients. 98 Finally, our results also confirm the recent findings of another group concerning gene expression abnormalities in GABA signal transmission in the cerebral cortex of subjects, who had suffered from depression and more specifically GABA(A) and GABA(B) alterations in individuals who died by suicide suggesting their potential role in suicidality. 62 Our findings together with previous studies clearly point to an alteration of gabaergic neurotransmission in suicide and major depression in the context of suicide and offers new potential pharmacological targets for the treatment of such complex disorders.…”
Section: Discussionsupporting
confidence: 91%
“…Also, SSRIs are known to increase GABA levels in the brain of depressed patients. 98 Finally, our results also confirm the recent findings of another group concerning gene expression abnormalities in GABA signal transmission in the cerebral cortex of subjects, who had suffered from depression and more specifically GABA(A) and GABA(B) alterations in individuals who died by suicide suggesting their potential role in suicidality. 62 Our findings together with previous studies clearly point to an alteration of gabaergic neurotransmission in suicide and major depression in the context of suicide and offers new potential pharmacological targets for the treatment of such complex disorders.…”
Section: Discussionsupporting
confidence: 91%
“…The observations presented here, suggesting a deficit in GABAergic neurons in depression, are supported by recent clinical reports of reduced GABA levels in plasma and cerebrospinal fluid in mood disorder patients (Brambilla et al, 2003;Petty, 1995;Sanacora et al, 1999Sanacora et al, , 2004. A proton magnetic resonance spectroscopy study in live patients shows a highly significant 52% reduction in GABA levels in the occipital cortex of 14 medication-free depressed subjects (Sanacora et al, 1999).…”
Section: Discussionsupporting
confidence: 87%
“…No significant differences in the density of calbindin-immunoreactive (CB-IR) or parvalbumin-immunoreactive (PV-IR) GABAergic neurons were found between MDD and control groups in either cortical region. However, clinical evidence is emerging to suggest that MDD is associated with reduced levels of GABA in the plasma, cerebrospinal fluid, and neocortex (Petty, 1995;Sanacora et al, 1999Sanacora et al, , 2000Sanacora et al, , 2004. A proton magnetic resonance spectroscopy study revealed a large, 52% reduction in GABA levels in the occipital cortex of 14 medication-free depressed subjects as compared to 18 healthy control subjects (Sanacora et al, 1999).…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…Higher field strength may better quantify Gln and separate it from Glu as evidenced by a 4-T study of left anterior cingulate finding reductions in both Glu and Gln in schizophrenia (Theberge et al, 2003). Furthermore, in addition to the Glu and Gln included in the LCModel fit of the Glx signal, some authors include a GABA contribution since their curve fitting algorithms do not differentiate GABA from the overlapping Glx peaks (Sanacora et al, 1999); nonetheless, this contribution is considered to be quite small.…”
Section: Discussionmentioning
confidence: 99%